1691752463 1_v4jh1b67

Matt E. has taken KESIMPTA® and has been compensated for his time.
Individual results may vary.

MY EXPERIENCE

quotesHey, I'm Matt. I'm a husband and father working in TV production in Maine. I'm pretty new to RMS, having been diagnosed in 2021, and KESIMPTA is my first RMS treatment. I love scootering with my son, working in the yard, and I hope to participate in a National MS Society event someday!

Taking Advice

The best advice I received was to involve my son from the very start. My journey started one hot summer day when I lost feeling in my right leg while mowing my lawn. This incident eventually led to my RMS diagnosis in March 2021. When I got the diagnosis, I honestly just thought about my son. How was I going to tell him? How was he going to react? He was just 12 years old at the time, but having an open conversation with him was the best thing I could have done because I don't have to hide anything. After all that worrying, he's been able to easily adapt to this whole thing and feel prepared for the future.

Needle Fear

When I talked to my doctor about treatments, he shared an infusion option and an injection option. I knew the infusion option was just not for me. But when he told me all about KESIMPTA and how the needle is hidden, I decided it was worth trying. I felt better hearing that it goes just under the skin, not into the muscle, and I can take it just once a month* at home.

Coordinator Connections

The Alongside™ KESIMPTA team has been a gift. It's something I didn't know I needed. They've communicated with me and guided me through any confusion or obstacle. Especially being a "newbie" to RMS, I've needed that extra support. No matter how many pamphlets you read, it's hard to know what questions I should be asking. Having the Alongside team reach out has been so great. I'm going to add my Coordinator, Lisa, to my speed dial!

Tips for "Newbies"†

Tips for "Newbies"†

There are a couple things I'd recommend to "newbies" like me. First, there is a lot of information and opinions out there. It's important to sift through what is relevant to you, and work with your doctor to find the right treatment choice for you. Second, get enough sleep. That goes for everyone, but I think it's especially important for people with MS. Getting enough sleep allows me and my body to be on our A game. Next, if heat is your archnemesis like it is mine, cool showers work for me. Lastly, don't be afraid to lean on loved ones for support. They won't think you are overbearing—that's all in your head. Communicating with my family, friends, and coworkers has been so encouraging for me.

Focused and Motivated

My focus is to stay motivated. That's all I can hope for at this time. The KESIMPTA data has really encouraged me to stay confident. I have so many future plans, from participating in a National MS Society walk to maybe watching my son become a father someday. I trust my body, my doctor, and my treatment to keep me going.quotes

*Once monthly after 3 weekly starter doses.

†Please consult your health care provider before making any changes to your lifestyle.

Maggie is a mom and recent college grad. She went from thinking her
life was over to accomplishing amazing things.

VIEW MAGGIE'S STORY BACK TO KESIMPTA STORIES

Maggie is a mom and recent college grad. She went from thinking her
life was over to accomplishing amazing things.

VIEW MAGGIE'S STORY BACK TO KESIMPTA STORIES

Get the results of the head-to-head studies vs AUBAGIO® (teriflunomide).

SEE THE RESULTS

Take a look at commonly
asked questions.

GET SOME ANSWERS
email

Looking for help navigating life with RMS?

Let us bring you personalized resources.
Sign Up

email

Looking for help navigating
life with RMS?

Let us bring you
personalized resources.

Sign Up

phone

Pay as little as $0 co-pay‡ & enroll in the
Alongside™ KESIMPTA Support Program.

Learn More

phone

Pay as little as $0 co-pay‡ &
enroll in the Alongside™
KESIMPTA Support Program.

Learn More

MS, multiple sclerosis; RMS, relapsing multiple sclerosis.

‡Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Patients with commercial insurance and an initial denial of coverage may receive up to 12 months of free product while coverage is pursued. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions at start.kesimpta.com.

+

-

IMPORTANT SAFETY INFORMATION

Who should not take KESIMPTA?

Do NOT take KESIMPTA if you:

  • have an active hepatitis B virus (HBV) infection.

  • have had an allergic reaction to ofatumumab or life-threatening

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS)

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple

IMPORTANT SAFETY INFORMATION & INDICATION

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.

It is not known if KESIMPTA is safe or effective in children.

IMPORTANT SAFETY INFORMATION

Who should not take KESIMPTA?

Do NOT take KESIMPTA if you:

  • have an active hepatitis B virus (HBV) infection.

  • have had an allergic reaction to ofatumumab or life-threatening injection-related reaction to KESIMPTA.

What is the most important information I should know about KESIMPTA?

KESIMPTA can cause serious side effects such as:

  • Infections. Serious infections, which can be life-threatening or cause death, can happen during treatment with KESIMPTA. If you have an active infection, your health care provider (HCP) should delay your treatment with KESIMPTA until your infection is gone. KESIMPTA taken before or after other medicines that weaken the immune system may increase your risk of getting infections. Tell your HCP right away if you have any infections or get any symptoms including painful and frequent urination, nasal congestion, runny nose, sore throat, fever, chills, cough, or body aches.

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.

It is not known if KESIMPTA is safe or effective in children.

  • HBV reactivation. If you have ever had HBV infection, it may become active again during or after treatment with KESIMPTA (reactivation). If this happens, it may cause serious liver problems including liver failure or death. Before starting KESIMPTA, your HCP will do a blood test to check for HBV. They will also continue to monitor you during and after treatment with KESIMPTA for HBV. Tell your HCP right away if you get worsening tiredness or yellowing of your skin or the white part of your eyes.

  • Progressive Multifocal Leukoencephalopathy (PML). PML may happen with KESIMPTA. PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. Tell your HCP right away if you have any new or worsening neurologic signs or symptoms. These may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory, which may lead to confusion and personality changes.

  • Weakened immune system. KESIMPTA taken before or after other medicines that weaken the immune system could increase your risk of getting infections.

Before you take KESIMPTA, tell your HCP about all your medical conditions, including if you:

  • Have or think you have an infection including HBV or PML.

  • Have ever taken, currently take, or plan to take medicines that affect your immune system. These medicines could increase your risk of getting an infection.

  • Have had a recent vaccination or are scheduled to receive any vaccinations.

    • You should receive any required 'live' or 'live-attenuated' vaccines at least 4 weeks before you start treatment with KESIMPTA. You should not receive 'live' or 'live-attenuated' vaccines while you are being treated with KESIMPTA and until your HCP tells you that your immune system is no longer weakened.

    • Whenever possible, you should receive any 'non-live' vaccines at least 2 weeks before you start treatment with KESIMPTA.

    • Talk to your HCP about vaccinations for your baby if you used KESIMPTA during your pregnancy.

  • Are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if KESIMPTA will harm your unborn baby. Females who can become pregnant should use birth control (contraception) during treatment with KESIMPTA and for 6 months after your last treatment. Talk with your HCP about what birth control method is right for you during this time.

  • Are breastfeeding or plan to breastfeed. It is not known if KESIMPTA passes into your breast milk. Talk to your HCP about the best way to feed your baby if you take KESIMPTA.

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use KESIMPTA?

See the detailed Instructions for Use that comes with KESIMPTA for information about how to prepare and inject a dose of KESIMPTA and how to properly throw away (dispose of) used KESIMPTA Sensoready pens or prefilled syringes.

  • Use KESIMPTA exactly as your HCP tells you to use it.

  • Your HCP will show you how to prepare and inject KESIMPTA the right way before you use it for the first time.

  • Do not inject into areas where the skin is tender, bruised, red, scaly or hard. Avoid areas with moles, scars, or stretch marks.

KESIMPTA may cause serious side effects including:

  • Injection-related reactions. Injection-related reactions are a common side effect of KESIMPTA. Injecting KESIMPTA can cause injection-related reactions that can happen within 24 hours (1 day) following the first injections and with later injections. There are two kinds of reactions:

    • at or near the injection site: redness of the skin, swelling, itching, and pain. Talk to your HCP if you have any of these signs and symptoms.

    • that may happen when certain substances are released in your body: fever, headache, pain in the muscles, chills, tiredness, rash, hives, trouble breathing, swelling of the face, eyelids, lips, mouth, tongue and throat, and feeling faint, or chest tightness. Contact your HCP right away if you experience any of these signs and symptoms, especially if they become worse or you have new severe signs of reactions after subsequent injections. It could be a sign of an allergic reaction, which can be serious.

  • Low immunoglobulins. KESIMPTA may cause a decrease in some types of antibodies. Your HCP will do blood tests to check your blood immunoglobulin levels.

The most common side effects of KESIMPTA include:

  • Upper respiratory tract infection, with symptoms such as sore throat and runny nose, and headache.

  • Headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information including Medication Guide.

KESIMPTA, the KESIMPTA logo, and SENSOREADY are registered trademarks of Novartis AG.

ALONGSIDE and the ALONGSIDE logo are trademarks of Novartis AG.

AUBAGIO is a registered trademark of Genzyme, a Sanofi company.

Please see each product's respective PI for additional information including indication, dosing, and safety.